MedTrace Logo

Pathway to Diagnosis of Ovarian Cancer

NCT01061619 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2023-03-24

No results posted yet for this study

Summary

The purpose of this study is to describe the prediagnostic symptoms and the events along the pathway to diagnosis of women with ovarian cancer, referred for first-line chemotherapy.

Conditions

Sponsors & Collaborators

  • National Cancer Institute, Naples

    lead OTHER

Principal Investigators

  • Sandro Pignata, M.D., Ph.D. · National Cancer Institute, Naples

  • Francesco Perrone, M.D., Ph.D. · National Cancer Institute, Naples

  • Alessandro Morabito, M.D., · National Cancer Institute, Naples

  • Ciro Gallo, M.D., Ph.D. · University of Campania Luigi Vanvitelli

  • Jane Bryce, MSN · National Cancer Institute, Naples

  • Marzia Falanga, BSN · S. Giuseppe Moscati Hospital, Avellino

  • Carmen Pisano, MD · National Cancer Institute, Naples

  • Marilina Piccirillo, MD · National Cancer Institute, Naples

  • Massimo Di Maio, M.D. · National Cancer Institute, Naples

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2024-11-30
Completion
2024-11-30

Countries

  • Belgium
  • Germany
  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01061619 on ClinicalTrials.gov